Thursday, November 15, 2018 8:53:15 AM
992% INCREASE IN REVENUE from Q2!!!!!!!
This is all that matters. FINS swam in and THEY ARE UP even having been throttle back on purpose! They could of been over $300k! See notes below:
Fundamentally going to BLOW your minds in the 2018 10K and Q1 of '19. They intentionally held back on reporting revenue (i.e. let the good doctors keep their cash) until they got PatientGain CRM implemented.
Revenue; our revenue has increased in Q3, it was however impacted by delays in training and launch of physicians. The company determined that delays in training some physicians until which time as the Patient Gain technology was implemented and our Generation 2 device technology was secured was of benefit to the company, the physicians and to their patients than booking sales in a given quarter opposed to the following quarter.
Wow. They did the OPPOSITE of cooking the books like so many other Co's. Instead, they went ABOVE AND BEYOND REPROACH so as to NOT put patients, doctors or the company at risk for jumping the gun to appease shareholders or market manipulators. STANDING OVATION PLEASE.
They shared that there are 14 locations ACTIVELY in progress. That's good for another $250k in revenue just for starters and the five locations CURRENTLY LIVE @ 5 treatments a week will generate at least $86,000 A MONTH NET!!!!!!!
14 LOCATIONS at 5 procedures a week (VERY LOW) will generate $240,800 PER MONTH NET to $CELZ. WOWZA.
Can't even imagine FEMCELZ coming online in 1.5 MONTHS!
This is about to get stupid good here folks, in my opinion.
I WILL BE BUYING MORE TODAY.
All posts my opinions, NOT investment advice. DO YOU OWN DUE DILIGENCE.
This is all that matters. FINS swam in and THEY ARE UP even having been throttle back on purpose! They could of been over $300k! See notes below:
Fundamentally going to BLOW your minds in the 2018 10K and Q1 of '19. They intentionally held back on reporting revenue (i.e. let the good doctors keep their cash) until they got PatientGain CRM implemented.
Revenue; our revenue has increased in Q3, it was however impacted by delays in training and launch of physicians. The company determined that delays in training some physicians until which time as the Patient Gain technology was implemented and our Generation 2 device technology was secured was of benefit to the company, the physicians and to their patients than booking sales in a given quarter opposed to the following quarter.
Wow. They did the OPPOSITE of cooking the books like so many other Co's. Instead, they went ABOVE AND BEYOND REPROACH so as to NOT put patients, doctors or the company at risk for jumping the gun to appease shareholders or market manipulators. STANDING OVATION PLEASE.
They shared that there are 14 locations ACTIVELY in progress. That's good for another $250k in revenue just for starters and the five locations CURRENTLY LIVE @ 5 treatments a week will generate at least $86,000 A MONTH NET!!!!!!!
14 LOCATIONS at 5 procedures a week (VERY LOW) will generate $240,800 PER MONTH NET to $CELZ. WOWZA.
Can't even imagine FEMCELZ coming online in 1.5 MONTHS!
This is about to get stupid good here folks, in my opinion.
I WILL BE BUYING MORE TODAY.
All posts my opinions, NOT investment advice. DO YOU OWN DUE DILIGENCE.
-- Narrow is the way and few are those who find it. --
Recent CELZ News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2026 08:45:54 PM
- Creative Medical Technology Holdings, Inc. Reports Breakthrough 93% Response Rate in Ultrasome™ Knee Osteoarthritis Program, Expanding CELZ-201 Platform into Scalable Cell-Free Regenerative Therapies • GlobeNewswire Inc. • 04/28/2026 01:01:00 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 04/24/2026 08:45:24 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/20/2026 08:45:28 PM
- Creative Medical Technology Holdings Achieves Second WHO INN Milestone, Strengthening Global Regulatory Positioning Across Expanding Cell Therapy Pipeline • GlobeNewswire Inc. • 02/10/2026 02:00:00 PM
- Creative Medical Technology Holdings Reaches Major Clinical Inflection Point with Positive Interim Data from ADAPT Trial and CELZ-201 (Olastrocel) in the Treatment of Chronic Lower Back Pain • GlobeNewswire Inc. • 01/13/2026 02:15:00 PM
- Creative Medical Technology Holdings Receives Regulatory Approval for BioDefense Burn Pit Initiative • GlobeNewswire Inc. • 01/06/2026 02:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/31/2025 09:05:39 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/19/2025 09:01:58 PM
- Creative Medical Technology Holdings, Inc. Completes Enrollment in FDA-Cleared ADAPT Trial for CELZ-201-Olastrocel, Marking Major Clinical Inflection Point • GlobeNewswire Inc. • 12/17/2025 02:15:00 PM
- Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 12/16/2025 09:05:24 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 12/15/2025 05:15:26 AM
- Creative Medical Technology Holdings Announces World Health Organization Approval of “olastrocel” as INN for Lead Allogeneic Cell Therapy CELZ-201 • GlobeNewswire Inc. • 12/02/2025 02:15:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 11/21/2025 09:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 11:12:58 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/07/2025 09:46:43 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 08:05:42 PM
- Creative Medical Technology Holdings, Inc. Ignites Next-Gen Regenerative BioDefense Initiative for U.S. Veterans Exposed to Burn Pits • GlobeNewswire Inc. • 10/30/2025 01:15:00 PM
- Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $4.2 Million Gross Proceeds • GlobeNewswire Inc. • 10/29/2025 01:00:00 PM
- Creative Medical Technology Holdings Issues Letter to Shareholders • GlobeNewswire Inc. • 10/27/2025 12:15:00 PM
- Creative Medical Technology Holdings Congratulates 2025 Nobel Laureates for Regulatory T Cell Breakthroughs • GlobeNewswire Inc. • 10/07/2025 01:15:00 PM
